Jochims Jeffrey T
Known title: EVP, Chief Operating OfficerCIK: 0001772914
Associated companies
Transaction History
| ACH | ▼ Sell | Open Market | 8,000 | $250K | 7/1/2022 | View on chart |
| ACH | ▲ Buy | Grant | 551 | $15K | 6/30/2022 | View on chart |
| ACH | ▼ Sell | Tax Withholding | 4,120 | $149K | 5/16/2022 | View on chart |
| ACH | ▼ Sell | Tax Withholding | 7,928 | $298K | 5/11/2022 | View on chart |
| ACH | ▼ Sell | Tax Withholding | 6,837 | $283K | 4/8/2022 | View on chart |
| ACH | ▲ Buy | Grant | 26,889 | $0 | 3/3/2022 | View on chart |
| ACH | ▲ Buy | Grant | 110,346 | $0 | 2/9/2022 | View on chart |
| ACH | ▼ Sell | Open Market | 7,500 | $299K | 12/15/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Accendra Health Receives NYSE Continued Listing Notice
Accendra Health received a notice from the NYSE regarding continued listing standards, with the company stating its intent to cure the deficiency. This regulatory development adds pressure to a stock that is already trading near its 52-week low. Additionally, Bank of America disclosed a 10.8% stake in the company as of September 30.
Accendra Health Receives NYSE Continued Listing Notice. Accendra Health received a notice from the NYSE regarding continued listing standards, with the company stating its intent to cure the deficiency. This regulatory development adds pressure to a stock that is already trading near its 52-week low. Additionally, Bank of America disclosed a 10.8% stake in the company as of September 30.